Rocky mountain spotted fever in the United States, 2000-2007: Interpreting contemporary increases in incidence

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 1, 2010, Pages 174-182

  Openshaw, John J ^a   Swerdlow, David L ^a   Krebs, John W ^a   Holman, Robert C ^a   Mandel, Eric ^a   Harvey, Alexis ^a   Haberling, Dana ^a   Massung, Robert F ^a   McQuiston, Jennifer H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHILD; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATALITY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RACE DIFFERENCE; RISK FACTOR; ROCKY MOUNTAIN SPOTTED FEVER; SCHOOL CHILD; SEASONAL VARIATION; UNITED STATES;

ANIMALS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INCIDENCE; QUESTIONNAIRES; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; UNITED STATES;

IXODIDA; RICKETTSIA RICKETTSII;

EID: 77954586750     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0752     Document Type: Article

References (51)

1. Helmick CG, Bernard KW, D'Angelo U, 1984. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 150: 480-488. (Pubitemid 14013966)
2. Dantas-Torres F, 2007. Rocky Mountain spotted fever. Lancet Infect Dis 7: 724-732.
3. Wilson LB, Chowning WM, 1904. Studies in pyroplasmosis hominis ("spotted fever" or "tick fever" of the Rocky Mountains. J Infect Dis 1: 31-57.
4. Rucker WC, 1912. Rocky Mountain spotted fever. Public Health Rep 27: 1465-1482.
5. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, Childs JE, 1995. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 52: 405-413.
6. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs JE, 2000. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg 63: 21-26. (Pubitemid 32423090)
7. Holman RC, Paddock CD, Curns AT, Krebs JW, McQuiston JH, Childs JE, 2001. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 184: 1437-1444.
8. Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumier SJ, Nicholson WL, Walker DH, Eremeeva ME, Ohl CA; Tickbkorne Rickettsial Diseases Working Group; CDC, 2006. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis - United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep 55: 1-27. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5504a1.htm. Accessed October 23, 2009.
9. Childs JE, Paddock CD, 2002. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 66: 450-457.
10. Chapman AS, Murphy SM, Demma LJ, Holman RC, Curns AT, McQuiston JH, Krebs JW, Swerdlow DL, 2006. Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis 6: 170-178. (Pubitemid 44082750)
11. Centers for Disease Control and Prevention, 2009. National Notifiable Diseases Surveillance System (NNDSS), 1980-2007. Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, Coordinating Center for Health Information and Service. Available at: http://www .cdc.gov/ncphi/disss/nndss/nndsshis.htm. Accessed October 22, 2009.
12. Centers for Disease Control and Prevention, 2009. National Electronic Telecommunications System for Surveillance (NETSS). Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, Coordinating Center for Health Information and Service. Available at: http://www.cdc.gov/ncphi/disss/nndss/netss.htm. Accessed October 22, 2009.
13. Centers for Disease Control and Prevention, 2009. Rocky Mountain Spotted Fever (Rickettsia rickettsii) (RMSF) 1996 Case Definition. Available at: http://www.cdc.gov/ncphi/disss/ nndss/casedef/rocky1996.htm Accessed October 23, 2009.
14. Centers for Disease Control and Prevention, 2009. Rocky Mountain Spotted Fever (Rickettsia rickettsii) (RMSF) 2004 Case Definition. http://www.cdc.gov/ ncphi/disss/nndss/casedef/ rocky2004.htm. Accessed 10/23/2009.
15. U.S. Census Bureau, 2009. State population estimates and demographic components of population change: 2000 to 2006. Available at: http://www.census.gov/popest/datasets.html. Accessed February 1, 2009.
16. EpiInfo version 6.0, 2009. Statcalc. Centers for Disease Control and Prevention. http://www.cdc.gov/epunfo/about.htm. Accessed October 22, 2009.
17. Marshall GS, Stout GG, Jacobs RF, Schultze GE, Paxton H, Buckingham SC, DeVincenzo JP, Jackson AM, San Joaquin VH, Standaert SM, Woods CR, TICS Group, 2003. Antibodies reactive to Rickettsia rickettsii among children living in the southeast and south central regions of the United States. Arch Pediatr Adolesc Med 157: 443-448.
18. Hilton E, DeVoti J, Benach JL, Halluska ML, White DJ, Paxton H, Dumler JS, 1999. Seroprevalence and seroconversion for tickborne diseases in a high-risk population in the northeast United States. Am J Med 106: 404-409.
19. Graf PCF, Chretien JP, Ung L, Gaydos JC, Richards AL, 2008. Prevalence of seropositivity to spotted fever group rickettsiae and Anaplasma phagocytophilum in a large, demographically diverse U.S. sample. CID 46: 70-77. (Pubitemid 351263562)
20. Reller ME, Clemens EG, Woods CW, Dumler JS, 2009. Serologic assessment of the burden of rickettsial infections in southern Sri Lanka. Abstract 56, presented at 23rd Meeting of the American Society for Rickettsiology, Hilton Head, SC, Aug 15-18, 2009.
21. Lochary ME, Lockhart PB, Williams WTJr, 1998. Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 17: 429-431.
22. O'Reilly M, Paddock C, Elchos B, Goddard J, Childs J, Currie M, 2003. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann N Y Acad Sci 990: 295-301. (Pubitemid 36808316)
23. American Academy of Pediatrics, 2009. Rocky Mountain spotted fever. Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. 2009 Red Book: Report of the Committee on Infectious Diseases. 28th edition. Elk Grove Village, IL: American Academy of Pediatrics, 573-575.
24. Holman RC, McQuiston JH, Haberling DL, Cheek JE, 2009. Increasing incidence of Rocky Mountain spotted fever among the American Indian population in the United States. Am J Trop Med Hyg 80: 601-605.
25. Demma LJ, Traeger MS, Nicholson WL, Paddock CD, Blau DM, Eremeeva ME, Dasch GA, Levin ML, Singleton J Jr, Zaki SR, Cheek JE, Swerdlow DL, McQuiston JH, 2005. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 11: 587-594.
26. Demma LJ, Holman RC, Mikosz CA, Curns AT, Swerdlow DL, Paisano EL, Cheek JE, 2006. Rocky Mountain spotted fever hospitalizations among American Indians. Am J Trop Med Hyg 75: 537-541. (Pubitemid 46941321)
27. McQuiston JH, Holman RC, Groom AV, Kaufman SF, Cheek JE, Childs JE, 2000. Incidence of Rocky Mountain spotted fever among American Indians in Oklahoma. Public Health Rep 115: 469-475. (Pubitemid 32150439)
28. Raoult D, Parola P, 2008. Rocky Mountain spotted fever in the USA: a benign disease or a common diagnostic error? Lancet 8: 587-589.
29. Centers for Disease Control and Prevention, 2008. Summary of notifiable diseases - United States, 2006. MMWR Recomm Rep 55: 1-94.
30. Paddock CD, Zaki SR, Koss T, Singleton J Jr, Sumner JW, Comer JA, Eremeeva ME, Dasch GA, Cherry B, Childs JE, 2003. Rickettsialpox in New York City: a persistent urban zoonosis. Ann N Y Acad Sci 990: 36-44. (Pubitemid 36808277)
31. Parola P, Labruna MB, Raoult D, 2009. Tick-borne rickettsioses in America: unanswered questions and emerging diseases. Curr Infect Dis Rep 11: 40-50.
32. Eremeeva ME, Bosserman EA, Demma LJ, Zambrano ML, Blau DM, Dasch GA, 2006. Isolation and identification of Rickettsia massiliae from Rhipicephalus sanguineus ticks collected in Arizona. Appl Environ Microbiol 72: 5569-5577.
33. Vitale G, Mansuelo S, Rolain JM, Raoult D, 2006. Rickettsia massiliae human isolation. Emerg Infect Dis 12: 174-175. (Pubitemid 43143563)
34. Raoult D, Paddock CD, 2005. Rickettsia parkeri infection and other spotted fevers in the United States. N Engl J Med 353: 626-627.
35. Paddock CD, Sumner JW, Comer JA, Zaki SR, Goldsmith CS, Goddard J, McLellan SL, Tamminga CL, Ohl CA, 2004. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 15: 805-811. (Pubitemid 38387226)
36. Paddock CD, 2005. Rickettsia parkeri as a paradigm for multiple causes of tick-borne spotted fever in the western hemisphere. Ann N Y Acad Sci 1063: 315-326.
37. Paddock CD, Finley RW, Wright CS, Robinson HN, Schrodt BJ, Lane CC, Ekenna O, Blass MA, Tamminga CL, Ohl CA, McLellan SL, Goddard J, Holman RC, Openshaw JJ, Sumner JW, Zaki SR, Eremeeva ME, 2008. Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis 47: 1188-1196.
38. Shapiro MR, Fritz CL, Tait K, Paddock CD, Nicholson WL, Abramowicz KF, Karpathy SE, Dasch GE, Sumner JW, Adem PV, Scott JJ, Padgett KA, Zaki SR, Eremeeva ME, 2010. Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis 50: 541-548.
39. Apperson CS, Engber B, Nicholson WL, Mead DG, Engel J, Yabsley MJ, Dail K, Johnson J, Watson DW, 2008.Tickborne diseases in North Carolina: is "Rickettsia amblyommii" a possible cause of rickettsiosis reported as Rocky Mountain spotted fever? Vector Borne Zoonotic Dis 8: 597-606.
40. Adjemian JZ, Krebs JW, Mandel E, McQuiston J, 2008. Spatial clustering by disease severity among reported Rocky Mountain spotted fever cases in the United States, 2001-2005. Am J Trop Med Hyg 80: 72-77.
41. La Scola B, Raoult D, 1997. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 35: 2715-2727. (Pubitemid 27452397)
42. Kaplan JE, Schonberger LB, 1986. The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg 35: 840-844.
43. Kantso B, Svendsen CB, Jorgensen CS, Krogfelt KA, 2009. Evaluation of serological tests for the diagnosis of rickettsiosis in Denmark. J Microbiol Methods 76: 285-288.
44. Walker DH, 2007. Rickettsiae and rickettsial infections: the current state of knowledge. Clin Infect Dis 45: S39-S44.
45. Walker DH, Paddock CD, Dumler JS, 2008. Emerging and reemerging tick-transmitted rickettsial and ehrlichial infections. Med Clin North Am 92: 1345-1361.
46. Parola P, Labruna MB, Raoult D, 2009. Tick-borne rickettsioses in America: unanswered questions and emerging diseases. Curr Infect Dis Rep 11: 40-50.
47. Paddock C, 2009.The science and fiction of emerging rickettsioses. Ann N Y Acad Sci 1166: 133-143.
48. Council of State and Territorial Epidemiologists, Public Health Reporting and National Notification for Spotted Fever Rickettsioses (including Rocky Mountain spotted fever), 2009. Position Statement 09-ID-16. Available at: http://www.cste.org/ ps2009/09-ID-16.pdf. Accessed October 23, 2009.
49. Centers for Disease Control and Prevention, 2009. Summary of notifiable diseases - United States, 2007. MMWR Recomm Rep 56: 1-100.
50. Brownstein JS, Holford TR, Fish D, 2005. Effect of climate change on lyme disease risk in North America. EcoHealth 2: 38-46.
51. Randolph SE, 2008. Dynamics of tick-borne disease systems: minor role of recent climate change. Rev Sci Tech 27: 367-381.